D-7000 HSM: SEPTIEMBRE Series: 0007 System: HPLC 1

2018

LABORATORIO FARBROQUIM S.A.S

Analyzed Date and Time: 06/09/18 07:06 p.m.
Processing Method: LEVOAMLO + CRA SEP/05/18 -
System(acquisition): HPLC MP-01 Vial Type: UNK
Sample Name: M1 LOTE 16009 Volume: 10,0 ul
Sample Description: ALENCAL IRBE 2,5 300 mg TABLET

N-Meth 0 0,03
0,25 Inhib Inhib 0,02
Sens 3
3,26, LEVOAMLODIPINO

0,01

0,20
0,00
Absorbance (AU)

2,0 2,2 2,4

0,15

0,10

0,05

0,00

0 1 2 3 4 5 6 7 8 9 10
Retention Time (min)

No. RT Name Area BC

CRA AMLODIPINO 0
1 3,26 LEVOAMLODIPINO 511807 BV

511807

Peak rejection level: 0

RT Name k' Asym N Res
(min) (USP) (USP)

3,26 LEVOAMLODIPINO 325,00 1,09 2222 ---

RT Name Alpha S/N Noise

(min) (uV)

3,26 LEVOAMLODIPINO --- 609,84 160,45

Asymmetry warning outside the range of: 0,800 to 2,000

No. of theoretical plates warning at less than: 500
Resolution warning at less than: 2,000

Page Indicator 1 / 2
D-7000 HSM: SEPTIEMBRE Series: 0007 System: HPLC 1
2018
Signal to noise ratio warning at less than: 3
Developed by: ANGELA GARCIA Analizado Por: SOFÍA CORREA

Page Indicator 2 / 2